Imaging. Prof Geneviève DERUMEAUX Hôpital Henri Mondor Créteil, FRANCE

Similar documents
Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

The new Guidelines: Focus on Chronic Heart Failure

When Should I Order a Stress Test or an Echocardiogram

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Acute Coronary Syndrome. Sonny Achtchi, DO

The use of Cardiac CT and MRI in Clinical Practice

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score

Advanced Imaging MRI and CTA

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

Rational use of imaging for viability evaluation

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Patient referral for elective coronary angiography: challenging the current strategy

Multi-imaging modality approach. Covadonga Fernández-Golfín Cardiac Imaging Unit. Cardiology Department. Ramón y Cajal Hospital.

Detailed Order Request Checklists for Cardiology

What the Cardiologist needs to know from Medical Images

ECG Workshop. Nezar Amir

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Imaging and heart failure

Patient characteristics Intervention Comparison Length of followup

Risk Stratification for CAD for the Primary Care Provider

Current and Future Imaging Trends in Risk Stratification for CAD

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

12 Lead EKG Chapter 4 Worksheet

7. Echocardiography Appropriate Use Criteria (by Indication)

CARDIAC IMAGING FOR SUBCLINICAL CAD

Chest Pain: To Cath or Not? Part I

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

IRM cardiaque en cancérologie: le rôle du radiologue

Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Potential recommendations for CT coronary angiography in athletes

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Takotsubo syndrome. Ευτυχία Σμπαρούνη, FACC, FESC

What is Your Diagnosis?

Εξελίξεις και νέες προοπτικές στην καρδιαγγειακή απεικόνιση CT. Σταμάτης Κυρζόπουλος Ωνάσειο Καρδιοχειρουργικό Κέντρο

Practitioner Education Course

The Role of Imaging in Transcatheter Aortic Valve Implantation

Case based learning: CMR in Heart Failure

Alicia Armour, MA, BS, RDCS

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

Diabetes and Occult Coronary Artery Disease

An update on the management of UA / NSTEMI. Michael H. Crawford, MD

J. Schwitter, MD, FESC Section of Cardiology

What s New in Cardiac MRI

Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Richard Grocott Mason

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011

ASE 2011 Appropriate Use Criteria for Echocardiography

Cardiovascular emergencies. 05/March/2014 László Rudas Szeged

Coronary artery disease (CAD) risk factors

Calcium scoring Clinical and prognostic value

Acute heart failure in a patient with lower urinary tract infection Case report of an infection-induced Reverse Takotsubo syndrome

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.

Pathophysiology of Coronary Microvascular Dysfunction

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

Stress Testing:Which Study is Indicated for My Patient?

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Susan P. D Anna MSN, APRN BC February 14, 2019

When is strain assessment mandatory?

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

A.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges For the STAR-Study-Group Herzzentrum Ludwigshafen, Germany

FFR in Multivessel Disease

Velocity Vector Imaging as a new approach for cardiac magnetic resonance: Comparison with echocardiography

Stress only Perfusion Imaging

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

8 th EuroCMR Meeting - Florence 2010 Start: Thursday, End: Saturday (+ CMR exam)

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Non Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal

SPECT CT Current Status and Future Direction Nuclear Cardiology

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Current Indications for Cardiac MRI: What You See is What You Get?

Preoperative Cardiac Risk Assessment: Approach & Guidelines

COMPARISON OF 2014 ACCAHA VS. ESC GUIDELINES EDITORIAL

Cardiac Imaging Tests

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

Ve V rmont rmon Card Car iac d Netw Ne ork tw Scott E. Friedman April 28, 2016

Chapter 5 Section 1.1. Diagnostic Radiology (Diagnostic Imaging)

Conflict Disclosures. Vermont Cardiac Network. Outline. Series Learning Objectives 4/27/2016. Scott E. Friedman April 28, 2016

TROPONINS HAVE THEY CHANGED YOUR

Transcription:

Imaging Prof Geneviève DERUMEAUX Hôpital Henri Mondor Créteil, FRANCE Conflicts of Interest Speaker/advisor/research grant for Actelion, Sanofi, Servier, Toshiba # esccongress www.escardio.org/esc2014

IMAGING TOPIC 1 New 2014 ESC guidelines TOPIC 2 Imaging Atherosclerosis Evaluation Risk marker TOPIC 3 LV function assessment

IMAGING Imaging in new 2014 guidelines # esccongress www.escardio.org/esc2014

2014 ESC/EACTS Guidelines on myocardial revascularization: Indications for imaging Symptomatic patients (Intermediate risk) Stress imaging IA CT Angiography IIa A Hybrid Imaging IIa B Knuuti, (FI) / Zamorano, (ES) / S. Windecker, (CH)

2014 ESC guidelines on the diagnosis and treatment of aortic diseases: Imaging of aorta Advantages/Limitations TTE TOE CT MRI Angio Ease of use +++ ++ +++ ++ + Diag. Reliability + +++ +++ +++ ++ Serial examinations ++ + ++(+) +++ - +++ only for follow-up after aortic stenting (metallic struts), otherwise limit radiation Repetitive imaging of the aorta diameter over time to assess change in diameter Use the same imaging modality IC Use similar method of measurement IC Lowest iatrogenic risk imaging IC R.Erbel (DE) / 1119

2014 ESC Guidelines on diagnosis/management of Hypertrophic Cardiomyopathy: CMR indications Diagnosis: detection of increased LV wall thickness Disease phenotype: myocardial fibrosis, abnormal MV apparatus coronary microcirculatory function ECG Echocardiography is central to the diagnosis and monitoring of HCM (IA in all pts.) P.M. Elliott (GB)

EURObservational research programme cardiomyopathy registry: Use of CMR/LGE 1115 consecutive patients who fulfilled conventional criteria for cardiomyopathy (26 centres) CMR LGE HCM HCM P.M. Elliott (GB)

2014 ESC Guidelines on diagnosis/management of acute pulmonary embolism: Central role of CT/Added value of Echo in unstable patients Suspected Acute PE with shock/hypotension CT available Class IC - No Echo Class IC RV Overload/Dysfunction + YES + Reperfusion therapy S.V. Konstantinides (GR)

IMAGING Imaging Atherosclerosis # esccongress www.escardio.org/esc2014

Systemic atherosclerotic inflammation following Acute Myocardial Infarction: Increased 18F-FDG PET uptake in remote atheroma In murine models, acute MI exacerbates atherosclerotic inflammation and progression : is it the same in humans? Regions of interests around aorta 18F-FDG PET study 40 pts. with recent MI - 40 pts. with stable angina 18F-FDG 18F-FDG tissue to background tissue to background ratios ratios 18F-FDG in stable angina and myocardial infarction 3.0 3.0 2.5 2.5 2.0 2.0 1.5 P<0.0001 P=0.03 Stable Angina (n=40) NSTEMI (n=14) STEMI (n=26) 1.5 In MI patients, 18F-FDG PET activity correlated with the size of the P<0.0001 infarct (troponin level) (r=0.43) p=0.01) P=0.03 Stable Angina (n=40) NSTEMI (n=14) STEMI (n=26) N.V. Joshi, (UK) /ESC Hot line session 2014

Myocardial Infarction (MI) Begets MI: The extent of MI predicts early recurrent MI 1003 patients from the GRACE registry Size of the initial infarct was an independent predictor of recurrent early MI at 30 days MI exacerbates systemic atherosclerotic inflammation, destabilises remote atheromatous plaque, causes an increase in early recurrent atherothrombotic events Survival free from recurrent Survival myocardial free from infarction recurrent (%) myocardial infarction (%) 100 100 98 96 94 92 90 88 98 96 94 92 90 88 Tertile-3 versus tertile-1: RR 4.30 [95%CI, 1.85-9.96], p=0.001 86 86 0 0 5 5 10 10 15 15 20 20 25 25 30 30 Troponin I Days Days from from index index event event D ays D ays 0 0 10 10 20 20 30 30 Tertile Tertile 1 1 332 332 326 326 324 324 323 323 Tertile Tertile 2 2 336 336 325 325 317 317 313 313 Tertile Tertile 3 3 335 335 312 312 304 304 298 298 Tertile Tertile 1 1 Tertile Tertile 2 2 Tertile Tertile 3 3 N.V. Joshi, (UK) /ESC Hot line session 2014

Epicardial Adipose Tissue: Relationship with plaque characteristics/vulnerability EAT was assessed in 406 patients referred for 64-slice CT Vulnerable coronary plaque components: presence of non-calcified plaque (NCP) High risk plaques and EAT thickness Factors EAT (>5.6mm) Gender (male) Diabetes Multiple logistic analysis after adjustment of age, hypertension, dyslipidemia Y. Morimitsu (JP) / P2549

Epicardial Adipose Tissue: Predicts progression of coronary artery calcification (CAC) EAT quantification To determine the association of EAT volume with progression of CAC-score in the general population (Heinz Nixdorf Recall Study) without known CAD MV-adjusted** CAC score at enrollment and after 5 years of follow-up in 3367 subjects Fat Volume Age Groupe All participants <55 (n=1136) 55-<65 (n=1372) % progression in CAC+1 (95% Cl) 6.1 (1.2-11.2) 19.8 (8.9-31.7) 2.5 (-4.8-10.4) p-value 0.01 0.0002 0.5 65 (n=859) 3.9 (-7.2-7.9) 0.98 A.A. Mahabadi (DE) / 3839

IMAGING LV Function assessment # esccongress www.escardio.org/esc2014

2D speckle-tracking after chest radiation: Detection of subclinical LV dysfunction Acute adverse effects of RT on cardiac function are not well characterised 40 women with left sided breast cancer, treated by lumpectomy without chemotherapy, undergoing only adjuvant RT (mean cumulative dose 58.9±9.5 Gy) Standard and 2D STE was obtained at baseline, during RT and 6 weeks post RT Parameter Baseline During RT 6 wks post RT P value LVEF (%) 63 ± 5 62 ± 4 62 ± 4 NS Global Long S -20.44 ± 2.66-18.60 ± 2.70 * -18.34 ± 2.86 * <0.05 Global Cir S -18.52 ± 3.45-19.20 ± 3.30-19.30 ± 2.86 NS Global Rad S 56.66 ± 18.57 46.93 ± 14.56 * 49.22 ± 15.81 * <0.05 Global Long Strain is modestly correlated with radiation dosage These findings may have implications in breast cancer patients receiving additional cardiotoxic chemotherapy Q. Lo (AU) / P644

3D speckle-tracking Echo (STE): Area strain but not LVEF predicts outcome in primary mitral regurgitation Management of asymptomatic pts. with primary MR remains controversial 41 asymptomatic pts. with severe primary MR and LVEF > 60% Clinical F-Up at 18 months Composite end-point (n=8): new onset of dyspnea, admission for heart failure Log rank test p=0.033 3D STE is a promising tool for predicting the development of symptoms E. Casas Rojo, (SP) / 226

HIGHLIGHT ON IMAGING 2014 TAKE HOME MESSAGE Imaging plays a major role in diagnosis and decisionmaking in cardiology Acute MI exacerbates systemic atherosclerotic inflammation and disease progression (18F FDG PET) Epicardial fat is a confirmed marker of advanced atherosclerosis LVEF underestimates the extent of LV dysfunction whereas 2D/3D strain imaging accurately detects LV impairment at an earlier stage (e.g., in breast cancer and in primary mitral regurgitation)

Welcome to LONDON 2015!